Global Circulating Tumor Cells Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at US$ 2357 million in 2024 and is forecast to a readjusted size of USD 8297 million by 2031 with a CAGR of 19.9% during review period.
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, Qiagen?Adnagen?, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.
This report is a detailed and comprehensive analysis for global Circulating Tumor Cells market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Circulating Tumor Cells market size and forecasts, in consumption value ($ Million), 2020-2031
Global Circulating Tumor Cells market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Circulating Tumor Cells market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Circulating Tumor Cells market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Circulating Tumor Cells
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Circulating Tumor Cells market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Menarini-Silicon Biosystems, Qiagen (Adnagen), Advanced Cell Diagnostics, ApoCell, Epic Sciences, Greiner Bio-one GmbH, Cynvenio, SurExamBio-Tech, Fluxion Biosciences, Ikonisys, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Circulating Tumor Cells market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Circulating Tumor Cells product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Circulating Tumor Cells, with revenue, gross margin, and global market share of Circulating Tumor Cells from 2020 to 2025.
Chapter 3, the Circulating Tumor Cells competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Circulating Tumor Cells market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Circulating Tumor Cells.
Chapter 13, to describe Circulating Tumor Cells research findings and conclusion.
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, Qiagen?Adnagen?, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.
This report is a detailed and comprehensive analysis for global Circulating Tumor Cells market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Circulating Tumor Cells market size and forecasts, in consumption value ($ Million), 2020-2031
Global Circulating Tumor Cells market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Circulating Tumor Cells market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Circulating Tumor Cells market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Circulating Tumor Cells
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Circulating Tumor Cells market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Menarini-Silicon Biosystems, Qiagen (Adnagen), Advanced Cell Diagnostics, ApoCell, Epic Sciences, Greiner Bio-one GmbH, Cynvenio, SurExamBio-Tech, Fluxion Biosciences, Ikonisys, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Circulating Tumor Cells market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- CTC Enrichment
- CTC Detection
- CTC Analysis
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Lung Cancer
- Others
- Menarini-Silicon Biosystems
- Qiagen (Adnagen)
- Advanced Cell Diagnostics
- ApoCell
- Epic Sciences
- Greiner Bio-one GmbH
- Cynvenio
- SurExamBio-Tech
- Fluxion Biosciences
- Ikonisys
- Hangzhou Watson Biotech
- Biocept
- CytoTrack
- Guangzhou Wondfo Biotech
- Celsee
- Clearbridge Biomedics
- ANGLE plc
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Circulating Tumor Cells product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Circulating Tumor Cells, with revenue, gross margin, and global market share of Circulating Tumor Cells from 2020 to 2025.
Chapter 3, the Circulating Tumor Cells competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Circulating Tumor Cells market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Circulating Tumor Cells.
Chapter 13, to describe Circulating Tumor Cells research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Circulating Tumor Cells by Type
1.3.1 Overview: Global Circulating Tumor Cells Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Circulating Tumor Cells Consumption Value Market Share by Type in 2024
1.3.3 CTC Enrichment
1.3.4 CTC Detection
1.3.5 CTC Analysis
1.4 Global Circulating Tumor Cells Market by Application
1.4.1 Overview: Global Circulating Tumor Cells Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Breast Cancer
1.4.3 Prostate Cancer
1.4.4 Colorectal Cancer
1.4.5 Lung Cancer
1.4.6 Others
1.5 Global Circulating Tumor Cells Market Size & Forecast
1.6 Global Circulating Tumor Cells Market Size and Forecast by Region
1.6.1 Global Circulating Tumor Cells Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Circulating Tumor Cells Market Size by Region, (2020-2031)
1.6.3 North America Circulating Tumor Cells Market Size and Prospect (2020-2031)
1.6.4 Europe Circulating Tumor Cells Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Circulating Tumor Cells Market Size and Prospect (2020-2031)
1.6.6 South America Circulating Tumor Cells Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Circulating Tumor Cells Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Menarini-Silicon Biosystems
2.1.1 Menarini-Silicon Biosystems Details
2.1.2 Menarini-Silicon Biosystems Major Business
2.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Product and Solutions
2.1.4 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Menarini-Silicon Biosystems Recent Developments and Future Plans
2.2 Qiagen (Adnagen)
2.2.1 Qiagen (Adnagen) Details
2.2.2 Qiagen (Adnagen) Major Business
2.2.3 Qiagen (Adnagen) Circulating Tumor Cells Product and Solutions
2.2.4 Qiagen (Adnagen) Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Qiagen (Adnagen) Recent Developments and Future Plans
2.3 Advanced Cell Diagnostics
2.3.1 Advanced Cell Diagnostics Details
2.3.2 Advanced Cell Diagnostics Major Business
2.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Product and Solutions
2.3.4 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Advanced Cell Diagnostics Recent Developments and Future Plans
2.4 ApoCell
2.4.1 ApoCell Details
2.4.2 ApoCell Major Business
2.4.3 ApoCell Circulating Tumor Cells Product and Solutions
2.4.4 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 ApoCell Recent Developments and Future Plans
2.5 Epic Sciences
2.5.1 Epic Sciences Details
2.5.2 Epic Sciences Major Business
2.5.3 Epic Sciences Circulating Tumor Cells Product and Solutions
2.5.4 Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Epic Sciences Recent Developments and Future Plans
2.6 Greiner Bio-one GmbH
2.6.1 Greiner Bio-one GmbH Details
2.6.2 Greiner Bio-one GmbH Major Business
2.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Product and Solutions
2.6.4 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Greiner Bio-one GmbH Recent Developments and Future Plans
2.7 Cynvenio
2.7.1 Cynvenio Details
2.7.2 Cynvenio Major Business
2.7.3 Cynvenio Circulating Tumor Cells Product and Solutions
2.7.4 Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Cynvenio Recent Developments and Future Plans
2.8 SurExamBio-Tech
2.8.1 SurExamBio-Tech Details
2.8.2 SurExamBio-Tech Major Business
2.8.3 SurExamBio-Tech Circulating Tumor Cells Product and Solutions
2.8.4 SurExamBio-Tech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 SurExamBio-Tech Recent Developments and Future Plans
2.9 Fluxion Biosciences
2.9.1 Fluxion Biosciences Details
2.9.2 Fluxion Biosciences Major Business
2.9.3 Fluxion Biosciences Circulating Tumor Cells Product and Solutions
2.9.4 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Fluxion Biosciences Recent Developments and Future Plans
2.10 Ikonisys
2.10.1 Ikonisys Details
2.10.2 Ikonisys Major Business
2.10.3 Ikonisys Circulating Tumor Cells Product and Solutions
2.10.4 Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Ikonisys Recent Developments and Future Plans
2.11 Hangzhou Watson Biotech
2.11.1 Hangzhou Watson Biotech Details
2.11.2 Hangzhou Watson Biotech Major Business
2.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Product and Solutions
2.11.4 Hangzhou Watson Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Hangzhou Watson Biotech Recent Developments and Future Plans
2.12 Biocept
2.12.1 Biocept Details
2.12.2 Biocept Major Business
2.12.3 Biocept Circulating Tumor Cells Product and Solutions
2.12.4 Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Biocept Recent Developments and Future Plans
2.13 CytoTrack
2.13.1 CytoTrack Details
2.13.2 CytoTrack Major Business
2.13.3 CytoTrack Circulating Tumor Cells Product and Solutions
2.13.4 CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 CytoTrack Recent Developments and Future Plans
2.14 Guangzhou Wondfo Biotech
2.14.1 Guangzhou Wondfo Biotech Details
2.14.2 Guangzhou Wondfo Biotech Major Business
2.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Product and Solutions
2.14.4 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Guangzhou Wondfo Biotech Recent Developments and Future Plans
2.15 Celsee
2.15.1 Celsee Details
2.15.2 Celsee Major Business
2.15.3 Celsee Circulating Tumor Cells Product and Solutions
2.15.4 Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Celsee Recent Developments and Future Plans
2.16 Clearbridge Biomedics
2.16.1 Clearbridge Biomedics Details
2.16.2 Clearbridge Biomedics Major Business
2.16.3 Clearbridge Biomedics Circulating Tumor Cells Product and Solutions
2.16.4 Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Clearbridge Biomedics Recent Developments and Future Plans
2.17 ANGLE plc
2.17.1 ANGLE plc Details
2.17.2 ANGLE plc Major Business
2.17.3 ANGLE plc Circulating Tumor Cells Product and Solutions
2.17.4 ANGLE plc Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 ANGLE plc Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Circulating Tumor Cells Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Circulating Tumor Cells by Company Revenue
3.2.2 Top 3 Circulating Tumor Cells Players Market Share in 2024
3.2.3 Top 6 Circulating Tumor Cells Players Market Share in 2024
3.3 Circulating Tumor Cells Market: Overall Company Footprint Analysis
3.3.1 Circulating Tumor Cells Market: Region Footprint
3.3.2 Circulating Tumor Cells Market: Company Product Type Footprint
3.3.3 Circulating Tumor Cells Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Circulating Tumor Cells Consumption Value and Market Share by Type (2020-2025)
4.2 Global Circulating Tumor Cells Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Circulating Tumor Cells Consumption Value Market Share by Application (2020-2025)
5.2 Global Circulating Tumor Cells Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Circulating Tumor Cells Consumption Value by Type (2020-2031)
6.2 North America Circulating Tumor Cells Market Size by Application (2020-2031)
6.3 North America Circulating Tumor Cells Market Size by Country
6.3.1 North America Circulating Tumor Cells Consumption Value by Country (2020-2031)
6.3.2 United States Circulating Tumor Cells Market Size and Forecast (2020-2031)
6.3.3 Canada Circulating Tumor Cells Market Size and Forecast (2020-2031)
6.3.4 Mexico Circulating Tumor Cells Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Circulating Tumor Cells Consumption Value by Type (2020-2031)
7.2 Europe Circulating Tumor Cells Consumption Value by Application (2020-2031)
7.3 Europe Circulating Tumor Cells Market Size by Country
7.3.1 Europe Circulating Tumor Cells Consumption Value by Country (2020-2031)
7.3.2 Germany Circulating Tumor Cells Market Size and Forecast (2020-2031)
7.3.3 France Circulating Tumor Cells Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Circulating Tumor Cells Market Size and Forecast (2020-2031)
7.3.5 Russia Circulating Tumor Cells Market Size and Forecast (2020-2031)
7.3.6 Italy Circulating Tumor Cells Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Circulating Tumor Cells Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Circulating Tumor Cells Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Circulating Tumor Cells Market Size by Region
8.3.1 Asia-Pacific Circulating Tumor Cells Consumption Value by Region (2020-2031)
8.3.2 China Circulating Tumor Cells Market Size and Forecast (2020-2031)
8.3.3 Japan Circulating Tumor Cells Market Size and Forecast (2020-2031)
8.3.4 South Korea Circulating Tumor Cells Market Size and Forecast (2020-2031)
8.3.5 India Circulating Tumor Cells Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Circulating Tumor Cells Market Size and Forecast (2020-2031)
8.3.7 Australia Circulating Tumor Cells Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Circulating Tumor Cells Consumption Value by Type (2020-2031)
9.2 South America Circulating Tumor Cells Consumption Value by Application (2020-2031)
9.3 South America Circulating Tumor Cells Market Size by Country
9.3.1 South America Circulating Tumor Cells Consumption Value by Country (2020-2031)
9.3.2 Brazil Circulating Tumor Cells Market Size and Forecast (2020-2031)
9.3.3 Argentina Circulating Tumor Cells Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Circulating Tumor Cells Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Circulating Tumor Cells Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Circulating Tumor Cells Market Size by Country
10.3.1 Middle East & Africa Circulating Tumor Cells Consumption Value by Country (2020-2031)
10.3.2 Turkey Circulating Tumor Cells Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Circulating Tumor Cells Market Size and Forecast (2020-2031)
10.3.4 UAE Circulating Tumor Cells Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Circulating Tumor Cells Market Drivers
11.2 Circulating Tumor Cells Market Restraints
11.3 Circulating Tumor Cells Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Circulating Tumor Cells Industry Chain
12.2 Circulating Tumor Cells Upstream Analysis
12.3 Circulating Tumor Cells Midstream Analysis
12.4 Circulating Tumor Cells Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Circulating Tumor Cells by Type
1.3.1 Overview: Global Circulating Tumor Cells Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Circulating Tumor Cells Consumption Value Market Share by Type in 2024
1.3.3 CTC Enrichment
1.3.4 CTC Detection
1.3.5 CTC Analysis
1.4 Global Circulating Tumor Cells Market by Application
1.4.1 Overview: Global Circulating Tumor Cells Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Breast Cancer
1.4.3 Prostate Cancer
1.4.4 Colorectal Cancer
1.4.5 Lung Cancer
1.4.6 Others
1.5 Global Circulating Tumor Cells Market Size & Forecast
1.6 Global Circulating Tumor Cells Market Size and Forecast by Region
1.6.1 Global Circulating Tumor Cells Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Circulating Tumor Cells Market Size by Region, (2020-2031)
1.6.3 North America Circulating Tumor Cells Market Size and Prospect (2020-2031)
1.6.4 Europe Circulating Tumor Cells Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Circulating Tumor Cells Market Size and Prospect (2020-2031)
1.6.6 South America Circulating Tumor Cells Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Circulating Tumor Cells Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Menarini-Silicon Biosystems
2.1.1 Menarini-Silicon Biosystems Details
2.1.2 Menarini-Silicon Biosystems Major Business
2.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Product and Solutions
2.1.4 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Menarini-Silicon Biosystems Recent Developments and Future Plans
2.2 Qiagen (Adnagen)
2.2.1 Qiagen (Adnagen) Details
2.2.2 Qiagen (Adnagen) Major Business
2.2.3 Qiagen (Adnagen) Circulating Tumor Cells Product and Solutions
2.2.4 Qiagen (Adnagen) Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Qiagen (Adnagen) Recent Developments and Future Plans
2.3 Advanced Cell Diagnostics
2.3.1 Advanced Cell Diagnostics Details
2.3.2 Advanced Cell Diagnostics Major Business
2.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Product and Solutions
2.3.4 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Advanced Cell Diagnostics Recent Developments and Future Plans
2.4 ApoCell
2.4.1 ApoCell Details
2.4.2 ApoCell Major Business
2.4.3 ApoCell Circulating Tumor Cells Product and Solutions
2.4.4 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 ApoCell Recent Developments and Future Plans
2.5 Epic Sciences
2.5.1 Epic Sciences Details
2.5.2 Epic Sciences Major Business
2.5.3 Epic Sciences Circulating Tumor Cells Product and Solutions
2.5.4 Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Epic Sciences Recent Developments and Future Plans
2.6 Greiner Bio-one GmbH
2.6.1 Greiner Bio-one GmbH Details
2.6.2 Greiner Bio-one GmbH Major Business
2.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Product and Solutions
2.6.4 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Greiner Bio-one GmbH Recent Developments and Future Plans
2.7 Cynvenio
2.7.1 Cynvenio Details
2.7.2 Cynvenio Major Business
2.7.3 Cynvenio Circulating Tumor Cells Product and Solutions
2.7.4 Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Cynvenio Recent Developments and Future Plans
2.8 SurExamBio-Tech
2.8.1 SurExamBio-Tech Details
2.8.2 SurExamBio-Tech Major Business
2.8.3 SurExamBio-Tech Circulating Tumor Cells Product and Solutions
2.8.4 SurExamBio-Tech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 SurExamBio-Tech Recent Developments and Future Plans
2.9 Fluxion Biosciences
2.9.1 Fluxion Biosciences Details
2.9.2 Fluxion Biosciences Major Business
2.9.3 Fluxion Biosciences Circulating Tumor Cells Product and Solutions
2.9.4 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Fluxion Biosciences Recent Developments and Future Plans
2.10 Ikonisys
2.10.1 Ikonisys Details
2.10.2 Ikonisys Major Business
2.10.3 Ikonisys Circulating Tumor Cells Product and Solutions
2.10.4 Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Ikonisys Recent Developments and Future Plans
2.11 Hangzhou Watson Biotech
2.11.1 Hangzhou Watson Biotech Details
2.11.2 Hangzhou Watson Biotech Major Business
2.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Product and Solutions
2.11.4 Hangzhou Watson Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Hangzhou Watson Biotech Recent Developments and Future Plans
2.12 Biocept
2.12.1 Biocept Details
2.12.2 Biocept Major Business
2.12.3 Biocept Circulating Tumor Cells Product and Solutions
2.12.4 Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Biocept Recent Developments and Future Plans
2.13 CytoTrack
2.13.1 CytoTrack Details
2.13.2 CytoTrack Major Business
2.13.3 CytoTrack Circulating Tumor Cells Product and Solutions
2.13.4 CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 CytoTrack Recent Developments and Future Plans
2.14 Guangzhou Wondfo Biotech
2.14.1 Guangzhou Wondfo Biotech Details
2.14.2 Guangzhou Wondfo Biotech Major Business
2.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Product and Solutions
2.14.4 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Guangzhou Wondfo Biotech Recent Developments and Future Plans
2.15 Celsee
2.15.1 Celsee Details
2.15.2 Celsee Major Business
2.15.3 Celsee Circulating Tumor Cells Product and Solutions
2.15.4 Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Celsee Recent Developments and Future Plans
2.16 Clearbridge Biomedics
2.16.1 Clearbridge Biomedics Details
2.16.2 Clearbridge Biomedics Major Business
2.16.3 Clearbridge Biomedics Circulating Tumor Cells Product and Solutions
2.16.4 Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Clearbridge Biomedics Recent Developments and Future Plans
2.17 ANGLE plc
2.17.1 ANGLE plc Details
2.17.2 ANGLE plc Major Business
2.17.3 ANGLE plc Circulating Tumor Cells Product and Solutions
2.17.4 ANGLE plc Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 ANGLE plc Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Circulating Tumor Cells Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Circulating Tumor Cells by Company Revenue
3.2.2 Top 3 Circulating Tumor Cells Players Market Share in 2024
3.2.3 Top 6 Circulating Tumor Cells Players Market Share in 2024
3.3 Circulating Tumor Cells Market: Overall Company Footprint Analysis
3.3.1 Circulating Tumor Cells Market: Region Footprint
3.3.2 Circulating Tumor Cells Market: Company Product Type Footprint
3.3.3 Circulating Tumor Cells Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Circulating Tumor Cells Consumption Value and Market Share by Type (2020-2025)
4.2 Global Circulating Tumor Cells Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Circulating Tumor Cells Consumption Value Market Share by Application (2020-2025)
5.2 Global Circulating Tumor Cells Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Circulating Tumor Cells Consumption Value by Type (2020-2031)
6.2 North America Circulating Tumor Cells Market Size by Application (2020-2031)
6.3 North America Circulating Tumor Cells Market Size by Country
6.3.1 North America Circulating Tumor Cells Consumption Value by Country (2020-2031)
6.3.2 United States Circulating Tumor Cells Market Size and Forecast (2020-2031)
6.3.3 Canada Circulating Tumor Cells Market Size and Forecast (2020-2031)
6.3.4 Mexico Circulating Tumor Cells Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Circulating Tumor Cells Consumption Value by Type (2020-2031)
7.2 Europe Circulating Tumor Cells Consumption Value by Application (2020-2031)
7.3 Europe Circulating Tumor Cells Market Size by Country
7.3.1 Europe Circulating Tumor Cells Consumption Value by Country (2020-2031)
7.3.2 Germany Circulating Tumor Cells Market Size and Forecast (2020-2031)
7.3.3 France Circulating Tumor Cells Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Circulating Tumor Cells Market Size and Forecast (2020-2031)
7.3.5 Russia Circulating Tumor Cells Market Size and Forecast (2020-2031)
7.3.6 Italy Circulating Tumor Cells Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Circulating Tumor Cells Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Circulating Tumor Cells Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Circulating Tumor Cells Market Size by Region
8.3.1 Asia-Pacific Circulating Tumor Cells Consumption Value by Region (2020-2031)
8.3.2 China Circulating Tumor Cells Market Size and Forecast (2020-2031)
8.3.3 Japan Circulating Tumor Cells Market Size and Forecast (2020-2031)
8.3.4 South Korea Circulating Tumor Cells Market Size and Forecast (2020-2031)
8.3.5 India Circulating Tumor Cells Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Circulating Tumor Cells Market Size and Forecast (2020-2031)
8.3.7 Australia Circulating Tumor Cells Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Circulating Tumor Cells Consumption Value by Type (2020-2031)
9.2 South America Circulating Tumor Cells Consumption Value by Application (2020-2031)
9.3 South America Circulating Tumor Cells Market Size by Country
9.3.1 South America Circulating Tumor Cells Consumption Value by Country (2020-2031)
9.3.2 Brazil Circulating Tumor Cells Market Size and Forecast (2020-2031)
9.3.3 Argentina Circulating Tumor Cells Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Circulating Tumor Cells Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Circulating Tumor Cells Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Circulating Tumor Cells Market Size by Country
10.3.1 Middle East & Africa Circulating Tumor Cells Consumption Value by Country (2020-2031)
10.3.2 Turkey Circulating Tumor Cells Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Circulating Tumor Cells Market Size and Forecast (2020-2031)
10.3.4 UAE Circulating Tumor Cells Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Circulating Tumor Cells Market Drivers
11.2 Circulating Tumor Cells Market Restraints
11.3 Circulating Tumor Cells Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Circulating Tumor Cells Industry Chain
12.2 Circulating Tumor Cells Upstream Analysis
12.3 Circulating Tumor Cells Midstream Analysis
12.4 Circulating Tumor Cells Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Circulating Tumor Cells Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Circulating Tumor Cells Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Circulating Tumor Cells Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Circulating Tumor Cells Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Menarini-Silicon Biosystems Company Information, Head Office, and Major Competitors
Table 6. Menarini-Silicon Biosystems Major Business
Table 7. Menarini-Silicon Biosystems Circulating Tumor Cells Product and Solutions
Table 8. Menarini-Silicon Biosystems Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Menarini-Silicon Biosystems Recent Developments and Future Plans
Table 10. Qiagen (Adnagen) Company Information, Head Office, and Major Competitors
Table 11. Qiagen (Adnagen) Major Business
Table 12. Qiagen (Adnagen) Circulating Tumor Cells Product and Solutions
Table 13. Qiagen (Adnagen) Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Qiagen (Adnagen) Recent Developments and Future Plans
Table 15. Advanced Cell Diagnostics Company Information, Head Office, and Major Competitors
Table 16. Advanced Cell Diagnostics Major Business
Table 17. Advanced Cell Diagnostics Circulating Tumor Cells Product and Solutions
Table 18. Advanced Cell Diagnostics Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. ApoCell Company Information, Head Office, and Major Competitors
Table 20. ApoCell Major Business
Table 21. ApoCell Circulating Tumor Cells Product and Solutions
Table 22. ApoCell Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. ApoCell Recent Developments and Future Plans
Table 24. Epic Sciences Company Information, Head Office, and Major Competitors
Table 25. Epic Sciences Major Business
Table 26. Epic Sciences Circulating Tumor Cells Product and Solutions
Table 27. Epic Sciences Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Epic Sciences Recent Developments and Future Plans
Table 29. Greiner Bio-one GmbH Company Information, Head Office, and Major Competitors
Table 30. Greiner Bio-one GmbH Major Business
Table 31. Greiner Bio-one GmbH Circulating Tumor Cells Product and Solutions
Table 32. Greiner Bio-one GmbH Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Greiner Bio-one GmbH Recent Developments and Future Plans
Table 34. Cynvenio Company Information, Head Office, and Major Competitors
Table 35. Cynvenio Major Business
Table 36. Cynvenio Circulating Tumor Cells Product and Solutions
Table 37. Cynvenio Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Cynvenio Recent Developments and Future Plans
Table 39. SurExamBio-Tech Company Information, Head Office, and Major Competitors
Table 40. SurExamBio-Tech Major Business
Table 41. SurExamBio-Tech Circulating Tumor Cells Product and Solutions
Table 42. SurExamBio-Tech Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. SurExamBio-Tech Recent Developments and Future Plans
Table 44. Fluxion Biosciences Company Information, Head Office, and Major Competitors
Table 45. Fluxion Biosciences Major Business
Table 46. Fluxion Biosciences Circulating Tumor Cells Product and Solutions
Table 47. Fluxion Biosciences Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Fluxion Biosciences Recent Developments and Future Plans
Table 49. Ikonisys Company Information, Head Office, and Major Competitors
Table 50. Ikonisys Major Business
Table 51. Ikonisys Circulating Tumor Cells Product and Solutions
Table 52. Ikonisys Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Ikonisys Recent Developments and Future Plans
Table 54. Hangzhou Watson Biotech Company Information, Head Office, and Major Competitors
Table 55. Hangzhou Watson Biotech Major Business
Table 56. Hangzhou Watson Biotech Circulating Tumor Cells Product and Solutions
Table 57. Hangzhou Watson Biotech Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Hangzhou Watson Biotech Recent Developments and Future Plans
Table 59. Biocept Company Information, Head Office, and Major Competitors
Table 60. Biocept Major Business
Table 61. Biocept Circulating Tumor Cells Product and Solutions
Table 62. Biocept Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Biocept Recent Developments and Future Plans
Table 64. CytoTrack Company Information, Head Office, and Major Competitors
Table 65. CytoTrack Major Business
Table 66. CytoTrack Circulating Tumor Cells Product and Solutions
Table 67. CytoTrack Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. CytoTrack Recent Developments and Future Plans
Table 69. Guangzhou Wondfo Biotech Company Information, Head Office, and Major Competitors
Table 70. Guangzhou Wondfo Biotech Major Business
Table 71. Guangzhou Wondfo Biotech Circulating Tumor Cells Product and Solutions
Table 72. Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Guangzhou Wondfo Biotech Recent Developments and Future Plans
Table 74. Celsee Company Information, Head Office, and Major Competitors
Table 75. Celsee Major Business
Table 76. Celsee Circulating Tumor Cells Product and Solutions
Table 77. Celsee Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Celsee Recent Developments and Future Plans
Table 79. Clearbridge Biomedics Company Information, Head Office, and Major Competitors
Table 80. Clearbridge Biomedics Major Business
Table 81. Clearbridge Biomedics Circulating Tumor Cells Product and Solutions
Table 82. Clearbridge Biomedics Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Clearbridge Biomedics Recent Developments and Future Plans
Table 84. ANGLE plc Company Information, Head Office, and Major Competitors
Table 85. ANGLE plc Major Business
Table 86. ANGLE plc Circulating Tumor Cells Product and Solutions
Table 87. ANGLE plc Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. ANGLE plc Recent Developments and Future Plans
Table 89. Global Circulating Tumor Cells Revenue (USD Million) by Players (2020-2025)
Table 90. Global Circulating Tumor Cells Revenue Share by Players (2020-2025)
Table 91. Breakdown of Circulating Tumor Cells by Company Type (Tier 1, Tier 2, and Tier 3)
Table 92. Market Position of Players in Circulating Tumor Cells, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 93. Head Office of Key Circulating Tumor Cells Players
Table 94. Circulating Tumor Cells Market: Company Product Type Footprint
Table 95. Circulating Tumor Cells Market: Company Product Application Footprint
Table 96. Circulating Tumor Cells New Market Entrants and Barriers to Market Entry
Table 97. Circulating Tumor Cells Mergers, Acquisition, Agreements, and Collaborations
Table 98. Global Circulating Tumor Cells Consumption Value (USD Million) by Type (2020-2025)
Table 99. Global Circulating Tumor Cells Consumption Value Share by Type (2020-2025)
Table 100. Global Circulating Tumor Cells Consumption Value Forecast by Type (2026-2031)
Table 101. Global Circulating Tumor Cells Consumption Value by Application (2020-2025)
Table 102. Global Circulating Tumor Cells Consumption Value Forecast by Application (2026-2031)
Table 103. North America Circulating Tumor Cells Consumption Value by Type (2020-2025) & (USD Million)
Table 104. North America Circulating Tumor Cells Consumption Value by Type (2026-2031) & (USD Million)
Table 105. North America Circulating Tumor Cells Consumption Value by Application (2020-2025) & (USD Million)
Table 106. North America Circulating Tumor Cells Consumption Value by Application (2026-2031) & (USD Million)
Table 107. North America Circulating Tumor Cells Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America Circulating Tumor Cells Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe Circulating Tumor Cells Consumption Value by Type (2020-2025) & (USD Million)
Table 110. Europe Circulating Tumor Cells Consumption Value by Type (2026-2031) & (USD Million)
Table 111. Europe Circulating Tumor Cells Consumption Value by Application (2020-2025) & (USD Million)
Table 112. Europe Circulating Tumor Cells Consumption Value by Application (2026-2031) & (USD Million)
Table 113. Europe Circulating Tumor Cells Consumption Value by Country (2020-2025) & (USD Million)
Table 114. Europe Circulating Tumor Cells Consumption Value by Country (2026-2031) & (USD Million)
Table 115. Asia-Pacific Circulating Tumor Cells Consumption Value by Type (2020-2025) & (USD Million)
Table 116. Asia-Pacific Circulating Tumor Cells Consumption Value by Type (2026-2031) & (USD Million)
Table 117. Asia-Pacific Circulating Tumor Cells Consumption Value by Application (2020-2025) & (USD Million)
Table 118. Asia-Pacific Circulating Tumor Cells Consumption Value by Application (2026-2031) & (USD Million)
Table 119. Asia-Pacific Circulating Tumor Cells Consumption Value by Region (2020-2025) & (USD Million)
Table 120. Asia-Pacific Circulating Tumor Cells Consumption Value by Region (2026-2031) & (USD Million)
Table 121. South America Circulating Tumor Cells Consumption Value by Type (2020-2025) & (USD Million)
Table 122. South America Circulating Tumor Cells Consumption Value by Type (2026-2031) & (USD Million)
Table 123. South America Circulating Tumor Cells Consumption Value by Application (2020-2025) & (USD Million)
Table 124. South America Circulating Tumor Cells Consumption Value by Application (2026-2031) & (USD Million)
Table 125. South America Circulating Tumor Cells Consumption Value by Country (2020-2025) & (USD Million)
Table 126. South America Circulating Tumor Cells Consumption Value by Country (2026-2031) & (USD Million)
Table 127. Middle East & Africa Circulating Tumor Cells Consumption Value by Type (2020-2025) & (USD Million)
Table 128. Middle East & Africa Circulating Tumor Cells Consumption Value by Type (2026-2031) & (USD Million)
Table 129. Middle East & Africa Circulating Tumor Cells Consumption Value by Application (2020-2025) & (USD Million)
Table 130. Middle East & Africa Circulating Tumor Cells Consumption Value by Application (2026-2031) & (USD Million)
Table 131. Middle East & Africa Circulating Tumor Cells Consumption Value by Country (2020-2025) & (USD Million)
Table 132. Middle East & Africa Circulating Tumor Cells Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Global Key Players of Circulating Tumor Cells Upstream (Raw Materials)
Table 134. Global Circulating Tumor Cells Typical Customers
Table 1. Global Circulating Tumor Cells Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Circulating Tumor Cells Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Circulating Tumor Cells Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Circulating Tumor Cells Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Menarini-Silicon Biosystems Company Information, Head Office, and Major Competitors
Table 6. Menarini-Silicon Biosystems Major Business
Table 7. Menarini-Silicon Biosystems Circulating Tumor Cells Product and Solutions
Table 8. Menarini-Silicon Biosystems Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Menarini-Silicon Biosystems Recent Developments and Future Plans
Table 10. Qiagen (Adnagen) Company Information, Head Office, and Major Competitors
Table 11. Qiagen (Adnagen) Major Business
Table 12. Qiagen (Adnagen) Circulating Tumor Cells Product and Solutions
Table 13. Qiagen (Adnagen) Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Qiagen (Adnagen) Recent Developments and Future Plans
Table 15. Advanced Cell Diagnostics Company Information, Head Office, and Major Competitors
Table 16. Advanced Cell Diagnostics Major Business
Table 17. Advanced Cell Diagnostics Circulating Tumor Cells Product and Solutions
Table 18. Advanced Cell Diagnostics Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. ApoCell Company Information, Head Office, and Major Competitors
Table 20. ApoCell Major Business
Table 21. ApoCell Circulating Tumor Cells Product and Solutions
Table 22. ApoCell Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. ApoCell Recent Developments and Future Plans
Table 24. Epic Sciences Company Information, Head Office, and Major Competitors
Table 25. Epic Sciences Major Business
Table 26. Epic Sciences Circulating Tumor Cells Product and Solutions
Table 27. Epic Sciences Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Epic Sciences Recent Developments and Future Plans
Table 29. Greiner Bio-one GmbH Company Information, Head Office, and Major Competitors
Table 30. Greiner Bio-one GmbH Major Business
Table 31. Greiner Bio-one GmbH Circulating Tumor Cells Product and Solutions
Table 32. Greiner Bio-one GmbH Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Greiner Bio-one GmbH Recent Developments and Future Plans
Table 34. Cynvenio Company Information, Head Office, and Major Competitors
Table 35. Cynvenio Major Business
Table 36. Cynvenio Circulating Tumor Cells Product and Solutions
Table 37. Cynvenio Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Cynvenio Recent Developments and Future Plans
Table 39. SurExamBio-Tech Company Information, Head Office, and Major Competitors
Table 40. SurExamBio-Tech Major Business
Table 41. SurExamBio-Tech Circulating Tumor Cells Product and Solutions
Table 42. SurExamBio-Tech Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. SurExamBio-Tech Recent Developments and Future Plans
Table 44. Fluxion Biosciences Company Information, Head Office, and Major Competitors
Table 45. Fluxion Biosciences Major Business
Table 46. Fluxion Biosciences Circulating Tumor Cells Product and Solutions
Table 47. Fluxion Biosciences Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Fluxion Biosciences Recent Developments and Future Plans
Table 49. Ikonisys Company Information, Head Office, and Major Competitors
Table 50. Ikonisys Major Business
Table 51. Ikonisys Circulating Tumor Cells Product and Solutions
Table 52. Ikonisys Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Ikonisys Recent Developments and Future Plans
Table 54. Hangzhou Watson Biotech Company Information, Head Office, and Major Competitors
Table 55. Hangzhou Watson Biotech Major Business
Table 56. Hangzhou Watson Biotech Circulating Tumor Cells Product and Solutions
Table 57. Hangzhou Watson Biotech Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Hangzhou Watson Biotech Recent Developments and Future Plans
Table 59. Biocept Company Information, Head Office, and Major Competitors
Table 60. Biocept Major Business
Table 61. Biocept Circulating Tumor Cells Product and Solutions
Table 62. Biocept Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Biocept Recent Developments and Future Plans
Table 64. CytoTrack Company Information, Head Office, and Major Competitors
Table 65. CytoTrack Major Business
Table 66. CytoTrack Circulating Tumor Cells Product and Solutions
Table 67. CytoTrack Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. CytoTrack Recent Developments and Future Plans
Table 69. Guangzhou Wondfo Biotech Company Information, Head Office, and Major Competitors
Table 70. Guangzhou Wondfo Biotech Major Business
Table 71. Guangzhou Wondfo Biotech Circulating Tumor Cells Product and Solutions
Table 72. Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Guangzhou Wondfo Biotech Recent Developments and Future Plans
Table 74. Celsee Company Information, Head Office, and Major Competitors
Table 75. Celsee Major Business
Table 76. Celsee Circulating Tumor Cells Product and Solutions
Table 77. Celsee Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Celsee Recent Developments and Future Plans
Table 79. Clearbridge Biomedics Company Information, Head Office, and Major Competitors
Table 80. Clearbridge Biomedics Major Business
Table 81. Clearbridge Biomedics Circulating Tumor Cells Product and Solutions
Table 82. Clearbridge Biomedics Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Clearbridge Biomedics Recent Developments and Future Plans
Table 84. ANGLE plc Company Information, Head Office, and Major Competitors
Table 85. ANGLE plc Major Business
Table 86. ANGLE plc Circulating Tumor Cells Product and Solutions
Table 87. ANGLE plc Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. ANGLE plc Recent Developments and Future Plans
Table 89. Global Circulating Tumor Cells Revenue (USD Million) by Players (2020-2025)
Table 90. Global Circulating Tumor Cells Revenue Share by Players (2020-2025)
Table 91. Breakdown of Circulating Tumor Cells by Company Type (Tier 1, Tier 2, and Tier 3)
Table 92. Market Position of Players in Circulating Tumor Cells, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 93. Head Office of Key Circulating Tumor Cells Players
Table 94. Circulating Tumor Cells Market: Company Product Type Footprint
Table 95. Circulating Tumor Cells Market: Company Product Application Footprint
Table 96. Circulating Tumor Cells New Market Entrants and Barriers to Market Entry
Table 97. Circulating Tumor Cells Mergers, Acquisition, Agreements, and Collaborations
Table 98. Global Circulating Tumor Cells Consumption Value (USD Million) by Type (2020-2025)
Table 99. Global Circulating Tumor Cells Consumption Value Share by Type (2020-2025)
Table 100. Global Circulating Tumor Cells Consumption Value Forecast by Type (2026-2031)
Table 101. Global Circulating Tumor Cells Consumption Value by Application (2020-2025)
Table 102. Global Circulating Tumor Cells Consumption Value Forecast by Application (2026-2031)
Table 103. North America Circulating Tumor Cells Consumption Value by Type (2020-2025) & (USD Million)
Table 104. North America Circulating Tumor Cells Consumption Value by Type (2026-2031) & (USD Million)
Table 105. North America Circulating Tumor Cells Consumption Value by Application (2020-2025) & (USD Million)
Table 106. North America Circulating Tumor Cells Consumption Value by Application (2026-2031) & (USD Million)
Table 107. North America Circulating Tumor Cells Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America Circulating Tumor Cells Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe Circulating Tumor Cells Consumption Value by Type (2020-2025) & (USD Million)
Table 110. Europe Circulating Tumor Cells Consumption Value by Type (2026-2031) & (USD Million)
Table 111. Europe Circulating Tumor Cells Consumption Value by Application (2020-2025) & (USD Million)
Table 112. Europe Circulating Tumor Cells Consumption Value by Application (2026-2031) & (USD Million)
Table 113. Europe Circulating Tumor Cells Consumption Value by Country (2020-2025) & (USD Million)
Table 114. Europe Circulating Tumor Cells Consumption Value by Country (2026-2031) & (USD Million)
Table 115. Asia-Pacific Circulating Tumor Cells Consumption Value by Type (2020-2025) & (USD Million)
Table 116. Asia-Pacific Circulating Tumor Cells Consumption Value by Type (2026-2031) & (USD Million)
Table 117. Asia-Pacific Circulating Tumor Cells Consumption Value by Application (2020-2025) & (USD Million)
Table 118. Asia-Pacific Circulating Tumor Cells Consumption Value by Application (2026-2031) & (USD Million)
Table 119. Asia-Pacific Circulating Tumor Cells Consumption Value by Region (2020-2025) & (USD Million)
Table 120. Asia-Pacific Circulating Tumor Cells Consumption Value by Region (2026-2031) & (USD Million)
Table 121. South America Circulating Tumor Cells Consumption Value by Type (2020-2025) & (USD Million)
Table 122. South America Circulating Tumor Cells Consumption Value by Type (2026-2031) & (USD Million)
Table 123. South America Circulating Tumor Cells Consumption Value by Application (2020-2025) & (USD Million)
Table 124. South America Circulating Tumor Cells Consumption Value by Application (2026-2031) & (USD Million)
Table 125. South America Circulating Tumor Cells Consumption Value by Country (2020-2025) & (USD Million)
Table 126. South America Circulating Tumor Cells Consumption Value by Country (2026-2031) & (USD Million)
Table 127. Middle East & Africa Circulating Tumor Cells Consumption Value by Type (2020-2025) & (USD Million)
Table 128. Middle East & Africa Circulating Tumor Cells Consumption Value by Type (2026-2031) & (USD Million)
Table 129. Middle East & Africa Circulating Tumor Cells Consumption Value by Application (2020-2025) & (USD Million)
Table 130. Middle East & Africa Circulating Tumor Cells Consumption Value by Application (2026-2031) & (USD Million)
Table 131. Middle East & Africa Circulating Tumor Cells Consumption Value by Country (2020-2025) & (USD Million)
Table 132. Middle East & Africa Circulating Tumor Cells Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Global Key Players of Circulating Tumor Cells Upstream (Raw Materials)
Table 134. Global Circulating Tumor Cells Typical Customers
LIST OF FIGURES
Figure 1. Circulating Tumor Cells Picture
Figure 2. Global Circulating Tumor Cells Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Circulating Tumor Cells Consumption Value Market Share by Type in 2024
Figure 4. CTC Enrichment
Figure 5. CTC Detection
Figure 6. CTC Analysis
Figure 7. Global Circulating Tumor Cells Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Circulating Tumor Cells Consumption Value Market Share by Application in 2024
Figure 9. Breast Cancer Picture
Figure 10. Prostate Cancer Picture
Figure 11. Colorectal Cancer Picture
Figure 12. Lung Cancer Picture
Figure 13. Others Picture
Figure 14. Global Circulating Tumor Cells Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Circulating Tumor Cells Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Market Circulating Tumor Cells Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 17. Global Circulating Tumor Cells Consumption Value Market Share by Region (2020-2031)
Figure 18. Global Circulating Tumor Cells Consumption Value Market Share by Region in 2024
Figure 19. North America Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 20. Europe Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 21. Asia-Pacific Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 22. South America Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 23. Middle East & Africa Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Circulating Tumor Cells Revenue Share by Players in 2024
Figure 26. Circulating Tumor Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 27. Market Share of Circulating Tumor Cells by Player Revenue in 2024
Figure 28. Top 3 Circulating Tumor Cells Players Market Share in 2024
Figure 29. Top 6 Circulating Tumor Cells Players Market Share in 2024
Figure 30. Global Circulating Tumor Cells Consumption Value Share by Type (2020-2025)
Figure 31. Global Circulating Tumor Cells Market Share Forecast by Type (2026-2031)
Figure 32. Global Circulating Tumor Cells Consumption Value Share by Application (2020-2025)
Figure 33. Global Circulating Tumor Cells Market Share Forecast by Application (2026-2031)
Figure 34. North America Circulating Tumor Cells Consumption Value Market Share by Type (2020-2031)
Figure 35. North America Circulating Tumor Cells Consumption Value Market Share by Application (2020-2031)
Figure 36. North America Circulating Tumor Cells Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Circulating Tumor Cells Consumption Value Market Share by Type (2020-2031)
Figure 41. Europe Circulating Tumor Cells Consumption Value Market Share by Application (2020-2031)
Figure 42. Europe Circulating Tumor Cells Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 44. France Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Circulating Tumor Cells Consumption Value Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Circulating Tumor Cells Consumption Value Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Circulating Tumor Cells Consumption Value Market Share by Region (2020-2031)
Figure 51. China Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 52. Japan Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 53. South Korea Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 54. India Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 55. Southeast Asia Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 56. Australia Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 57. South America Circulating Tumor Cells Consumption Value Market Share by Type (2020-2031)
Figure 58. South America Circulating Tumor Cells Consumption Value Market Share by Application (2020-2031)
Figure 59. South America Circulating Tumor Cells Consumption Value Market Share by Country (2020-2031)
Figure 60. Brazil Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 61. Argentina Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 62. Middle East & Africa Circulating Tumor Cells Consumption Value Market Share by Type (2020-2031)
Figure 63. Middle East & Africa Circulating Tumor Cells Consumption Value Market Share by Application (2020-2031)
Figure 64. Middle East & Africa Circulating Tumor Cells Consumption Value Market Share by Country (2020-2031)
Figure 65. Turkey Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 66. Saudi Arabia Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 67. UAE Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 68. Circulating Tumor Cells Market Drivers
Figure 69. Circulating Tumor Cells Market Restraints
Figure 70. Circulating Tumor Cells Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Circulating Tumor Cells Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Circulating Tumor Cells Picture
Figure 2. Global Circulating Tumor Cells Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Circulating Tumor Cells Consumption Value Market Share by Type in 2024
Figure 4. CTC Enrichment
Figure 5. CTC Detection
Figure 6. CTC Analysis
Figure 7. Global Circulating Tumor Cells Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Circulating Tumor Cells Consumption Value Market Share by Application in 2024
Figure 9. Breast Cancer Picture
Figure 10. Prostate Cancer Picture
Figure 11. Colorectal Cancer Picture
Figure 12. Lung Cancer Picture
Figure 13. Others Picture
Figure 14. Global Circulating Tumor Cells Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Circulating Tumor Cells Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Market Circulating Tumor Cells Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 17. Global Circulating Tumor Cells Consumption Value Market Share by Region (2020-2031)
Figure 18. Global Circulating Tumor Cells Consumption Value Market Share by Region in 2024
Figure 19. North America Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 20. Europe Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 21. Asia-Pacific Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 22. South America Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 23. Middle East & Africa Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Circulating Tumor Cells Revenue Share by Players in 2024
Figure 26. Circulating Tumor Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 27. Market Share of Circulating Tumor Cells by Player Revenue in 2024
Figure 28. Top 3 Circulating Tumor Cells Players Market Share in 2024
Figure 29. Top 6 Circulating Tumor Cells Players Market Share in 2024
Figure 30. Global Circulating Tumor Cells Consumption Value Share by Type (2020-2025)
Figure 31. Global Circulating Tumor Cells Market Share Forecast by Type (2026-2031)
Figure 32. Global Circulating Tumor Cells Consumption Value Share by Application (2020-2025)
Figure 33. Global Circulating Tumor Cells Market Share Forecast by Application (2026-2031)
Figure 34. North America Circulating Tumor Cells Consumption Value Market Share by Type (2020-2031)
Figure 35. North America Circulating Tumor Cells Consumption Value Market Share by Application (2020-2031)
Figure 36. North America Circulating Tumor Cells Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Circulating Tumor Cells Consumption Value Market Share by Type (2020-2031)
Figure 41. Europe Circulating Tumor Cells Consumption Value Market Share by Application (2020-2031)
Figure 42. Europe Circulating Tumor Cells Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 44. France Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Circulating Tumor Cells Consumption Value Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Circulating Tumor Cells Consumption Value Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Circulating Tumor Cells Consumption Value Market Share by Region (2020-2031)
Figure 51. China Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 52. Japan Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 53. South Korea Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 54. India Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 55. Southeast Asia Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 56. Australia Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 57. South America Circulating Tumor Cells Consumption Value Market Share by Type (2020-2031)
Figure 58. South America Circulating Tumor Cells Consumption Value Market Share by Application (2020-2031)
Figure 59. South America Circulating Tumor Cells Consumption Value Market Share by Country (2020-2031)
Figure 60. Brazil Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 61. Argentina Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 62. Middle East & Africa Circulating Tumor Cells Consumption Value Market Share by Type (2020-2031)
Figure 63. Middle East & Africa Circulating Tumor Cells Consumption Value Market Share by Application (2020-2031)
Figure 64. Middle East & Africa Circulating Tumor Cells Consumption Value Market Share by Country (2020-2031)
Figure 65. Turkey Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 66. Saudi Arabia Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 67. UAE Circulating Tumor Cells Consumption Value (2020-2031) & (USD Million)
Figure 68. Circulating Tumor Cells Market Drivers
Figure 69. Circulating Tumor Cells Market Restraints
Figure 70. Circulating Tumor Cells Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Circulating Tumor Cells Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
